SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3441
- By:
- Publication type:
- Article
Works matching IS 1099498X AND DT 2022 AND VI 24 AND IP 8
Results: 6
1
2
Long non‐coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR‐326/PKM2 axis.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3440
- By:
- Publication type:
- Article
3
Downregulation of indolethylamine N‐methyltransferase is an early event in the rat hepatocarcinogenesis and is associated with poor prognosis in hepatocellular carcinoma patients.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3439
- By:
- Publication type:
- Article
4
Intramyocardial adenoviral vascular endothelial growth factor‐D<sup>∆N∆C</sup> gene therapy does not induce ventricular arrhythmias.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3437
- By:
- Publication type:
- Article
5
Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR‐1/MAP 3 K1 axis.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3376
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- Journal of Gene Medicine, 2022, v. 24, n. 8, p. 1, doi. 10.1002/jgm.3357
- Publication type:
- Article